Tag:
Cancidas
Latest Headlines
Latest Headlines
Positive Phase II results for fungal infection drug
Merck has unveiled interim Phase II data for Cancidas, an antifungal drug for pediatric patients with candidiasis, esophageal candidiasis or invasive aspergillosis. Seventy-four percent of trial
